Advertisement

Reactivity of Cultured Mouse Natural Killer (NK) Cells Against Normal Non-Neoplastic Cells

  • C. Riccardi
  • G. Migliorati
  • L. Frati
  • F. Guadagni
  • E. Bonmassar
  • R. B. Herberman

Abstract

In the last few years much interest has evolved in the study of natural reactivity (1). Studies from many laboratories have demonstrated that cells from different lymphoid tissues, including spleen and peripheral blood, show a spontaneous reactivity against neoplastic cells (2). This spontaneous reactivity, mediated by NK lymphocytes, has been shown to play a major role in the rapid elimination in vivo of neoplastic as well as of normal non-neoplastic targets including syngeneic bone marrow, thymocytes and fibroblasts (3–4). This reactivity directed against normal cells suggest an autocytotoxic function of NK effectors which could be involved in the homeostatic control of growth and differentiation of normal tissues (5–6). Also in vitro experiments showed some spontaneous reactivity against 51Cr-labelled non-neoplastic cells, but in this case it was not possible to obtain high cytotoxic levels of reactivity, comparable to those found against neoplastic targets (7–8). This fact is probably due to the low frequency of NK cells able to recognize “self” structures as targets. More recently it has been shown that it is possible to cultivate in vitro splenocytes of normal mice in the presence of T-cell-growth-factor (TCGF) and that these cultures generate lymphocytes with NK cell-like activity (9–10).

Keywords

Cytotoxic Activity Spleen Cell Peritoneal Exudate Cell Culture Spleen Cell Natural Killer Lymphocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Natural Resistance System Against Foreign Cell, Tumors and Microbes, eds. Cudkowicz G., Landy M., and Shearer G.M., Academic Press, New York, 1982.Google Scholar
  2. 2.
    NK Cells and Other Natural Effector Cells, ed. R.B. Herbermann, Academic Press, New York, 1982.Google Scholar
  3. 3.
    C. Riccardi, A. Santoni, T. Barlozzari and R.B. Herberman: Role of NK cells in rapid in vivo clearance of radio-labeled tumor cells. In “Natural Cell-Mediated Immunity Against Tumors” ed. R.B. Herberman, Academic Press, New York, p. 1121, 1980.Google Scholar
  4. 4.
    C. Riccardi, A. Santoni, T. Barlozzari, C. Cesarini and R.B. Herberman: In vivo role of NK cells against neo-plastic or non-neoplastic cells. In “Human Cancer Immunology”, North-Holland Press, vol.4 p. 57, 1982.Google Scholar
  5. 5.
    C. Riccardi, A. Santoni, T. Barlozzari and R.B. Herberman: In vivo Reactivity of mouse Natural Killer (NK) cells against Normal Bone Marrow Cells. Cell.Immunol., 60, 136, 1981.PubMedCrossRefGoogle Scholar
  6. 6.
    G. Cudkowicz and P.S. Hochman: Do Natural Killer Cells Engage in Regulater Reactions Against Self to Ensure Homeostasis. Immunol. Rev., 44, 13, 1979.PubMedCrossRefGoogle Scholar
  7. 7.
    M.E. Nunn, R.B. Herberman and H.T. Holden: Natural cell-mediated cytotoxicity in mice against nonlymphoid tumor cells and some normal cells. Int. J. Cancer, 20, 381, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    M. Hansson, R. Kiessling, B. Andersson, K. Kärre and J. Roder: Natural Killer (NK) cell sensitive T-cell sub-population in the thymus: inverse correlation to NK activity of the host. Nature, 278, 174, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    C. Riccardi, B.M. Vose and R.B.Herberman: Regulation by Interferon and T cells of IL-2-dependent growth of NK progenitor cells: a limiting dilution analysis. In “NK Celles and Other Natural Effector Cells” ed. R.B. Herberman, Academic Press, New York, pag. 909, 1982.Google Scholar
  10. 10.
    C. Riccardi, B.M. Vose and R.B. Herberman: Modulation of IL-2-dependent growth of mouse NK celles by interferon and T lymphocites. J. Immunol., 130, 228, 1983.PubMedGoogle Scholar
  11. 11.
    C. Riccardi, G. Migliorati and R.B. Herberman: Partially Restorative Role of T Cells for Low IL-2-Dependent Growth of NK Cell Progenitors from Nude Mice. Submitted for publication.Google Scholar
  12. 12.
    K. Nakano, I. Nakamura and G. Cudkowicz: Generation of F1 hybrid cytotoxic T lymphocytes specific for self H-2. Nature, 289, 559, 1981.PubMedCrossRefGoogle Scholar
  13. 13.
    G.M. Shearer and G. Cudkowicz: Induction of F1 hybrid antiparental cytotoxic effector cells: an in vitro model for hemopoietic Histoincompatibility. Science 190, 890, 1975.PubMedCrossRefGoogle Scholar
  14. 14.
    C. Riccardi, G. Migliorati and L. Frati: Induction of Naturally Cytotoxic Cells by T-Cell-Growth-Factor: Auto-Cytotoxic Activity Against Syngenic Non-Neoplastic Cells. Proc. 13th International Congress of Chemotherapy, in press, 1983.Google Scholar
  15. 15.
    J. Tarkkanen: Interferon-evidenced autologous reactivity of human natural killer cells. Scand. J. Immunol., 17, 513, 1983.PubMedCrossRefGoogle Scholar
  16. 16.
    C.S. Henney, K. Kuribayashi, P.E. Kern and S. Gillis: Interleukin 2 augments natural killer cell activity. Nature, 291, 335, 1981.PubMedCrossRefGoogle Scholar
  17. 17.
    H. Ishikawa and R.W. Dutton: Characterization of the target antigen of F1 antiparent cytotoxic lympholysis: analysis of the spontaneous in vitro F1 cytotoxic T lymphocytes. J.Immunol., 125, 656, 1980.PubMedGoogle Scholar
  18. 18.
    R. Kiessling, P.S. Hochman, O. Haller, G.M. Shearer, H. Wigzell and G. Cudkowicz: Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol., 7, 655, 1977.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • C. Riccardi
    • 1
  • G. Migliorati
    • 1
  • L. Frati
    • 2
  • F. Guadagni
    • 1
  • E. Bonmassar
    • 2
  • R. B. Herberman
    • 3
  1. 1.Inst.of PharmacologyUniv.of PerugiaItaly
  2. 2.Inst.of General PathologyUniv.of RomeItaly
  3. 3.Frederik Cancer CenterNCI, NIH, BRMFrederikUSA

Personalised recommendations